Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

2.30USD
16 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.30
Open
$2.24
Day's High
$2.31
Day's Low
$2.24
Volume
2,616
Avg. Vol
53,669
52-wk High
$15.90
52-wk Low
$2.03

Chart for

About

Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $23.88
Shares Outstanding(Mil.): 13.92
Dividend: --
Yield (%): --

Financials

  CLRB.OQ Industry Sector
P/E (TTM): -- 31.23 33.59
EPS (TTM): -1.24 -- --
ROI: -103.68 15.57 15.05
ROE: -105.20 16.94 16.62

Earnings vs. Estimates